BAL GUPTA: Open Payments
NPI 1225041353 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 18 payments from 7 companies in 2025. Trend: 2023 $545 · 2024 $223 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $122 |
| Axsome Therapeutics, Inc. | 5 | $114 |
| ABBVIE INC. | 3 | $85 |
| Alkermes, Inc. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Validus Pharmaceuticals LLC | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: REXULTI, Auvelity, VRAYLAR, ARISTADA, INVEGA SUSTENNA, EQUETRO, FANAPT.
Industry payments across MI — which companies pay providers there.
